The Food and Drugs Authority (FDA) of Ghana has approved a herbal medicine for clinical trial on COVID-19.
Cryptolepis Sanguinolenta, popularly known as Nibima, has been tested in the laboratories of Kwame Nkrumah University of Science and Technology (KNUST).
In a statement, the FDA CEO Delese Darko said the herbal medicine has some “clinical benefits” hence its approval for clinical trials.
“It is hoped that data from this study may be useful to inform policy or be used for scientific judgments and opinions in relation to COVID-19,” the statement read in part.
Attached is the full statement:
Eleven additional COVID-19 related deaths have been recorded in Ghana bringing the number of fatalities from 405 to 416.
In an address to the nation Sunday night, President Akufo-Addo said sixty-four (64) people have succumbed to the virus as at Friday, January 29, 2021.
Mr Akufo-Addo said one hundred and seventy-two (172) patients are said to be severely ill and are being monitored at health facilities across the country.
“Our hospitals have become full and we have had to reactivate our isolation centers”, the President said.
Source: Daily Mail GH